Yalei Zhang

First Affiliated Hospital of Guangzhou Medical University — China

Immunology and Microbiology · Life Sciences

9h-index550citations25works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(8), Cancer Immunotherapy and Biomarkers(7), Cell Adhesion Molecules Research(7), Virus-based gene therapy research(4), Lung Cancer Treatments and Mutations(3)

Publications25 total

Pathological complete response in RET-positive non-small cell lung cancer: a case report of pralsetinib-based “sandwich” therapy
Translational Lung Cancer Research·2025Open Access
Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
Molecular Therapy·2024· 22 citedOpen Access
An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
Scientific Reports·2024· 1 citedOpen Access
EP01.01-15 Study on Risk Prediction Model of PD1/PD-L1 Inhibitor-associated Pneumonia
Journal of Thoracic Oncology·2023Open Access
Data from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
2023Open Access
Figure S1 from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
2023Open Access
Data from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
2023Open Access
Figure S1 from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
2023Open Access
Table S1 from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
2023Open Access
Table S1 from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
2023Open Access
Inflammatory/immune-suppressive microenvironment characteristics of pancreatic cancer patients with Shi-Re syndrome identified by extracellular vesicle long RNA profiling
Traditional Medicine Research·2023· 1 citedOpen Access
Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
Canadian Respiratory Journal·2022· 2 citedOpen Access
Oncolytic virotherapy against the tumor microenvironment and its potential in pancreatic cancer
Journal of Cancer Research and Therapeutics·2022· 10 citedOpen Access
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response
Molecular Therapy — Oncolytics·2022· 35 citedOpen Access
Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2021· 47 cited
Circulating EVs long RNA-based subtyping and deconvolution enable prediction of immunogenic signatures and clinical outcome for PDAC
Molecular Therapy — Nucleic Acids·2021· 24 citedOpen Access
Emerging strategies to target RAS signaling in human cancer therapy
Journal of Hematology & Oncology·2021· 225 citedOpen Access
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
Cancer Cell International·2021· 64 citedOpen Access
Inflammatory/immune-suppressive microenvironment characteristics of pancreatic cancer patients with Shi-Re ZHENG identified by extracellular vesicle long RNA profiling
2021Open Access
Increased macrophage inflammation response in pancreatic cancer patients with a diagnosis of Shi-Re
TMR Modern Herbal Medicine·2021Open Access
page 1 of 2Next →

Frequent Co-authors

Peng Wang(7), Shasha Ruan(7), Lawrence G. Lum(7), Archana Thakur(7), Runming Jin(7), Wenlong Shao(7), Shiang Huang(7), Elaine M. Hurt(7), Alfred E. Chang(7), Max S. Wicha(7), Qiao Li(7), Kun Chen(6), Ling Qian(6), Ming Lin(6), Yong‐Guan Zhu(6), Yang‐Yang Hu(6), Sijia Gu(4), Ye Li(4), Jianxing He(4), Kun Chen(3)